The Role of Age and Sex in Non-linear Dilution Adjustment of Spot Urine Arsenic

Overview

Journal BMC Nephrol

Publisher Biomed Central

Specialty Nephrology

Date 2024 Oct 13

PMID 39396936

Authors

Thomas Clemens Carmine

Affiliations

Soon will be listed here.

Abstract

Background: Previous research introduced V-PFCRC as an effective spot urinary dilution adjustment method for various metal analytes, including the major environmental toxin arsenic. V-PFCRC normalizes analytes to 1 g/L creatinine (CRN) by adopting more advanced power-functional corrective equations accounting for variation in exposure level. This study expands on previous work by examining the impacts of age and sex on corrective functions.

Methods: Literature review of the effects of sex and age on urinary dilution and the excretion of CRN and arsenic. Data analysis included a Data Set 1 of 5,752 urine samples and a partly overlapping Data Set 2 of 1,154 combined EDTA blood and urine samples. Both sets were classified into age bands, and the means, medians, and interquartile ranges for CRN and TWuAs in uncorrected (UC), conventionally CRN-corrected (CCRC), simple power-functional (S-PFCRC), sex-aggregated (V-PFCRC SA), and sex-differentiated V-PFCRC SD modes were compared. Correlation analyses assessed residual relationships between CRN, TWuAs, and age. V-PFCRC functions were compared across three numerically similar age groups and both sexes. The efficacy of systemic dilution adjustment error compensation was evaluated through power-functional regression analysis of residual CRN and the association between arsenic in blood and all tested urinary result modes.

Results: Significant sex differences in UC and blood were neutralized by CCRC and reduced by V-PFCRC. Age showed a positive association with blood arsenic and TWuAs in all result modes, indicating factual increments in exposure. Sex-differentiated V-PFCRC best matched the sex-age kinetics of blood arsenic. V-PFCRC formulas varied by sex and age and appeared to reflect urinary osmolality sex-age-kinetics reported in previous research. V-PFCRC minimized residual biases of CRN on TWuAs across all age groups and sexes, demonstrating improved standardization efficacy compared to UC and CCRC arsenic.

Interpretation: Sex differences in UC and CCRC arsenic are primarily attributable to urinary dilution and are effectively compensated by V-PFCRC. While the sex and age influence on V-PFCRC formulas align with sex- and age-specific urinary osmolality and assumed baseline vasopressor activities, their impact on correction validity for entire collectives is minimal.

Conclusion: The V-PFCRC method offers a robust correction for urinary arsenic dilution, significantly reducing systemic dilution adjustment errors. Its application in various demographic contexts enhances the accuracy of urinary biomarker assessments, benefiting clinical and epidemiological research. V-PFCRC effectively compensates for sex differences in urinary arsenic. Age-related increases in TWuAs are exposure-related and should be additionally accounted for by algebraic normalization, covariate models, or standard range adjustments.

Citing Articles

Variable power functional dilution adjustment of spot urine.

Carmine T Sci Rep. 2025; 15(1):3688.

PMID: 39885184 PMC: 11782553. DOI: 10.1038/s41598-024-84442-9.

References

Peters B, Hall M, Liu X, Neugut Y, Pilsner J, Levy D . Creatinine, arsenic metabolism, and renal function in an arsenic-exposed population in Bangladesh. PLoS One. 2014; 9(12):e113760. PMC: 4249915. DOI: 10.1371/journal.pone.0113760. View

Liu J, Chen H, Miller D, Saavedra J, Keefer L, Johnson D . Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol. 2001; 60(2):302-9. DOI: 10.1124/mol.60.2.302. View

Nishizawa K, Yoda N, Morokado F, Komori H, Nakanishi T, Tamai I . Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia. PLoS One. 2019; 14(4):e0214862. PMC: 6450621. DOI: 10.1371/journal.pone.0214862. View

Perucca J, Bouby N, Valeix P, Bankir L . Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am J Physiol Regul Integr Comp Physiol. 2006; 292(2):R700-5. DOI: 10.1152/ajpregu.00500.2006. View

Claybaugh J, Sato A, Crosswhite L, Hassell L . Effects of time of day, gender, and menstrual cycle phase on the human response to a water load. Am J Physiol Regul Integr Comp Physiol. 2000; 279(3):R966-73. DOI: 10.1152/ajpregu.2000.279.3.R966. View

Sabolic I, Asif A, Budach W, Wanke C, Bahn A, Burckhardt G . Gender differences in kidney function. Pflugers Arch. 2007; 455(3):397-429. DOI: 10.1007/s00424-007-0308-1. View

Ozdemir S, Sears C, Harrington J, Poulsen A, Buckley J, Howe C . Relationship between Urine Creatinine and Urine Osmolality in Spot Samples among Men and Women in the Danish Diet Cancer and Health Cohort. Toxics. 2021; 9(11). PMC: 8625939. DOI: 10.3390/toxics9110282. View

Bankir L, Perucca J, Weinberger M . Ethnic differences in urine concentration: possible relationship to blood pressure. Clin J Am Soc Nephrol. 2007; 2(2):304-12. DOI: 10.2215/CJN.03401006. View

Brosnan J, da Silva R, Brosnan M . The metabolic burden of creatine synthesis. Amino Acids. 2011; 40(5):1325-31. DOI: 10.1007/s00726-011-0853-y. View

10.

Komukai K, Mochizuki S, Yoshimura M . Gender and the renin-angiotensin-aldosterone system. Fundam Clin Pharmacol. 2010; 24(6):687-98. DOI: 10.1111/j.1472-8206.2010.00854.x. View

11.

Toering T, Gant C, Visser F, van der Graaf A, Laverman G, Danser A . Sex differences in renin-angiotensin-aldosterone system affect extracellular volume in healthy subjects. Am J Physiol Renal Physiol. 2017; 314(5):F873-F878. DOI: 10.1152/ajprenal.00109.2017. View

12.

Stachenfeld N . Sex hormone effects on body fluid regulation. Exerc Sport Sci Rev. 2008; 36(3):152-9. PMC: 2849969. DOI: 10.1097/JES.0b013e31817be928. View

13.

Grikiniene J, Volbekas V, Stakisaitis D . Gender differences of sodium metabolism and hyponatremia as an adverse drug effect. Medicina (Kaunas). 2004; 40(10):935-42. View

14.

de Vries G, Wang Z, Bullock N, Numan S . Sex differences in the effects of testosterone and its metabolites on vasopressin messenger RNA levels in the bed nucleus of the stria terminalis of rats. J Neurosci. 1994; 14(3 Pt 2):1789-94. PMC: 6577591. View

15.

Stachenfeld N, Dipietro L, Palter S, Nadel E . Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women. Am J Physiol. 1998; 274(1):R187-95. DOI: 10.1152/ajpregu.1998.274.1.R187. View

16.

Nishimura K, Yoshino K, Sanada K, Beppu H, Akiyama Y, Nishimura H . Effect of oestrogen-dependent vasopressin on HPA axis in the median eminence of female rats. Sci Rep. 2019; 9(1):5153. PMC: 6435644. DOI: 10.1038/s41598-019-41714-z. View

17.

Herzberg N, Goudsmit E, Kruisbrink J, Boer G . Testosterone treatment restores reduced vasopressin-binding sites in the kidney of the ageing rat. J Endocrinol. 1989; 123(1):59-63. DOI: 10.1677/joe.0.1230059. View

18.

Pavo I, Varga C, Szucs M, Laszlo F, Szecsi M, Gardi J . Effects of testosterone on the rat renal medullary vasopressin receptor concentration and the antidiuretic response. Life Sci. 1995; 56(14):1215-22. DOI: 10.1016/0024-3205(95)00061-a. View

19.

Chang A, Abdullah S, Jain T, Stanek H, Das S, McGuire D . Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol. 2007; 49(1):109-16. DOI: 10.1016/j.jacc.2006.10.040. View

20.

Oparil S, EHRLICH E, Lindheimer M . Effect of progesterone on renal sodium handling in man: relation to aldosterone excretion and plasma renin activity. Clin Sci Mol Med. 1975; 49(2):139-47. DOI: 10.1042/cs0490139. View